少妇人妻一区二区三区I五月婷婷婷婷I亚洲深夜avI天天爽网站I91手机免费视频I久久97视频I国产毛片在线I亚洲一区二区电影I都市激情综合I羞羞的视频在线观看I久久99亚洲精品I日本专区在线I爆操日本美女I亚洲天堂伦理Iwww.亚洲欧美I大陆一级黄色片I免费观看毛片网站I麻豆精品免费I悠悠色影院I成人三级做爰视频在线看I欧美高清视频在线观看I蜜桃导航-精品导航I中文字幕精品一区二区精I淫片aaaI亚洲欧美第一视频I国产精品美女高潮无套

18611095289

down

資料下載

當(dāng)前位置:首頁(yè)資料下載人抗膜聯(lián)蛋白V檢測(cè)試劑盒Anti Annexin V IgG ELISA kit說(shuō)明書(shū)

人抗膜聯(lián)蛋白V檢測(cè)試劑盒Anti Annexin V IgG ELISA kit說(shuō)明書(shū)

發(fā)布時(shí)間:2023/11/8點(diǎn)擊次數(shù):640

人抗膜聯(lián)蛋白V檢測(cè)試劑盒


Human Anti Annexin V IgG ELISA kit



cat#3300-240-AVA


Intended Use


Human Anti-Annexin V IgG kit is for Quantitative Determination of IgGclass autoantibodies to anti- Annexin V in human serum or plasma.

General Information


Anti phospholipid syndrome (APS, Hughes Syndrome) is a systemic autoimmunedisease that causes thromboses, recurrent miscarriage, and intrauterine foetaldeath. Clinical symptoms are accompanied by the occurrence of specificautoantibodies that are detectable in the blood of patients with APS. Theseantibodies bind to phospholipids like cardiolipin, or phospholipid-binding proteinslike beta-2-glycoprotein I. The clinical symptoms of APS alone are not sufficientlyspecific to make a definitive diagnosis. Laboratory tests thus play an importantrole in the diagnosis of the disease.The diagnosis of APS is considered as confirmed when at least one clinical andone of the laboratory criteria are fulfilled. In primary APS autoantibodies againstphospholipids appear independently, while in secondary APS phospholipidantibodies are detected in conjunction with other autoimmune diseases, such aslupus erythematosus, rheumatoid arthritis, or Sj?gren’s syndrome. Phospholipidantibodies are detectable in only 1-5 % of healthy individuals, but they are foundin 16-35 % of lupus patients.


Sensitivity:Functional sensitivity was determined to be 1 U/ml.


Parallelism


In dilution experiments sera with high antibody concentrations were diluted withsample buffer and assayed in the Annexin V kit. The assay showed linearity overthe full measuring range.


Measuring range:


The calculation range of this ELISA assay is 0 - 100 U/ml


Interfering substances


No interference has been observed with haemolytic (up to 1000 mg/dl) or lipemic(up to 3 g/dl triglycerides) sera or plasma, or bilirubin (up to 40 mg/dl) containingsera or plasma. Nor have any interfering effects been observed with the use ofanticoagulants (Citrate, EDTA, Heparine). However for practical reasons it isrecommended that grossly hemolyzed or lipemic samples should be avoided.


更多產(chǎn)品信息,請(qǐng)聯(lián)系 Alpha Diagnostic 中國(guó)區(qū)總代理 北京博蕾德生物科技有限公司。

文件下載    

服務(wù)熱線
18611095289

掃碼加微信

主站蜘蛛池模板: 筠连县| 博爱县| 光泽县| 阿拉善右旗| 互助| 岳阳县| 梅州市| 寻乌县| 康保县| 永川市| 吉林省| 青冈县| 米易县| 乐至县| 兴国县| 临高县| 台南县| 泰安市| 通山县| 巴马| 奈曼旗| 富民县| 德安县| 嘉兴市| 静安区| 资源县| 三明市| 黑龙江省| 乳山市| 武穴市| 东乡| 江口县| 福鼎市| 宜黄县| 深圳市| 新邵县| 栾城县| 南安市| 白玉县| 邛崃市| 尖扎县|